Blockstream has unveiled Simplicity, a new smart contract language built natively for Bitcoin, designed as a fundamentally ...

Earlier this week, a prominent venture capitalist named Geoff Lewis — the managing partner of the multi-billion dollar investment firm Bedrock, which has backed high-profile tech companies including ...

The exodus stretched the waiting line to over 9 days, but strong staking demand from ETH treasury firms and SEC clarity on staking may keep sell pressure in check.

SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...

The REV102 program originated from a joint venture between Rallybio and Recursion focused on the discovery and development of novel, orally available small molecule inhibitors of ENPP1 for the ...

Recursion acquires full interest in Rallybio's ENPP1 inhibitor program to develop a potential oral treatment for hypophosphatasia.

B stacks up against GPT-4o in practical tests. From coding to logic and creativity, here’s the side-by-side you’ve been ...

Recursion Pharmaceuticals ( (RXRX)) just unveiled an announcement. On July 8, 2025, Recursion Pharmaceuticals acquired full ownership of the ENPP1 inhibitor program, REV102, from Rallybio, aiming ...